These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2039199)

  • 1. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.
    Iwahi T; Satoh H; Nakao M; Iwasaki T; Yamazaki T; Kubo K; Tamura T; Imada A
    Antimicrob Agents Chemother; 1991 Mar; 35(3):490-6. PubMed ID: 2039199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
    Nakao M; Tada M; Tsuchimori K; Uekata M
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):391-9. PubMed ID: 7556227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
    Nakao M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S32-7. PubMed ID: 7673612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Nakao M; Malfertheiner P
    Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of lansoprazole and omeprazole against Helicobacter pylori in vitro.
    Vogt K; Hahn H
    Arzneimittelforschung; 1998 Jun; 48(6):694-7. PubMed ID: 9689430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
    Alarcón T; Domingo D; Sánchez I; Sanz JC; Martínez MJ; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):275-7. PubMed ID: 9707312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori.
    Kawakami Y; Akahane T; Yamaguchi M; Oana K; Takahashi Y; Okimura Y; Okabe T; Gotoh A; Katsuyama T
    Antimicrob Agents Chemother; 2000 Feb; 44(2):458-61. PubMed ID: 10639386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR; Bell JM
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.
    Nagata K; Sone N; Tamura T
    Antimicrob Agents Chemother; 2001 May; 45(5):1522-7. PubMed ID: 11302821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth.
    Nakajima N; Kuwayama H; Iwasaki A; Arakawa Y
    J Clin Gastroenterol; 1995; 20 Suppl 2():S90-2. PubMed ID: 7594352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
    Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro susceptibilities of Helicobacter pylori strains from children to proton pump inhibitors and its thioether derivative].
    Taneike I; Tamura Y; Shimizu T; Yamashiro Y; Toyoda S; Yamamoto T
    Kansenshogaku Zasshi; 2000 Jul; 74(7):601-2. PubMed ID: 10965666
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro activity of lansoprazole against Helicobacter pylori.
    Figura N; Crabtree JE; Dattilo M
    J Antimicrob Chemother; 1997 May; 39(5):585-90. PubMed ID: 9184356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori.
    Tsutsui N; Taneike I; Ohara T; Goshi S; Kojio S; Iwakura N; Matsumaru H; Wakisaka-Saito N; Zhang HM; Yamamoto T
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3069-73. PubMed ID: 11036024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined activity of azithromycin and lansoprazole against Helicobacter pylori.
    Trautmann M; Riediger C; Möricke A; Vogt K; Bohr U; Glasbrenner B
    Helicobacter; 1999 Jun; 4(2):113-20. PubMed ID: 10382125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract]   [Full Text] [Related]  

  • 18. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.
    Hirai M; Azuma T; Ito S; Kato T; Kohli Y
    J Gastroenterol; 1995 Aug; 30(4):461-4. PubMed ID: 7550855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
    Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
    Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection.
    de Boer WA; van Etten RJ; Lai JY; Schneeberger PM; van de Wouw BA; Driessen WM
    Helicobacter; 1996 Sep; 1(3):145-50. PubMed ID: 9398895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.